Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU

NCT ID: NCT05500118

Last Updated: 2022-08-12

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 120 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-08-31
• Study Completion Date: 2027-08-31

Brief Summary

With the younger patients diagnosed with asymptomatic leiomyoma, delay in the reproductive age of women, the advancement of medical technology, and the rapid development of treatment methods, there are many choices between gynecologists, gynecologists and patients because of experience and knowledge. It is not easy to make the most favorable choice for patients. This study is mainly led by a committee composed of designers, doctors, nurses and patients, and based on clinical guidelines and evidence-based medicine. Co-operating with patients with asymptomatic small leiomyoma, we want to find the influencing factors of clinical decision-making, and to establish a patient decision aid tool. We use prospective trial to verify that the use of this tool can improve patients' decision-making efficacy and further improve patient-reported outcomes.

Conditions

Leiomyoma, Uterine; High-Intensity Focused Ultrasound Ablation; Patients Decision Aids

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

communication without PADs

We use traditional communication ways to discuss the conditions with patients.

No interventions assigned to this group

communication with PADs

The committee, composed of designers, doctors, nurses and patients, bases on guidelines and evidence-based medicine to make a tool. And we use this tool to discuss the conditions with patients.

Patients Decision Aids

Intervention Type: OTHER

Patient Decision Aids (PDAs) are an important way to facilitate making decision by patients, helping patients make specific and prudent choices by providing information about treatment options and corresponding outcomes, including benefits and risks, related to their health status. The purpose of PDAs is to encourage patients to participate in decision-making. It makes it easier for patients and doctors to discuss treatment options. It effectively promotes communication between patients and doctors. It can help patients combine their own needs and professional advice to make better, more individualized diagnosis and treatment options.

Interventions

Patients Decision Aids

Patient Decision Aids (PDAs) are an important way to facilitate making decision by patients, helping patients make specific and prudent choices by providing information about treatment options and corresponding outcomes, including benefits and risks, related to their health status. The purpose of PDAs is to encourage patients to participate in decision-making. It makes it easier for patients and doctors to discuss treatment options. It effectively promotes communication between patients and doctors. It can help patients combine their own needs and professional advice to make better, more individualized diagnosis and treatment options.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Diagnosis of leiomyoma: patients with leiomyoma diagnosed by imaging examinations (ultrasound and MRI) have no clinical symptoms;

2. Female with age in 18-55 years old;

3. The maximum diameter of a single leiomyoma is less than 5m, and the number does not exceed 10 by MRI;

4. No contraindications for sedation and analgesia;

5. Patients and their families agree to join this study, and can follow up on time.

Exclusion Criteria

1. History of myomectomy, including transabdominal, laparoscopic, hysteroscopy, etc.;

2. History of connective tissue diseases or radiotherapy, especially abdominal radiotherapy;

3. With pregnancy, acute inflammation of the reproductive tract, or other gynecological benign and malignant diseases such as endometriosis and ovarian tumors;

4. The maximum diameter of leiomyoma is greater than or equal to 5cm;

5. Suspected malignant tumor, such as sarcoma;

6. Those with language communication barriers and unable to cooperate with sedative and analgesic programs;

7. Abdominal scarring, when diagnosed by ultrasound transabdominal scan, has obvious sound attenuation (more than 10mm range).

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 55 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Shenzhen Maternity & Child Healthcare Hospital

OTHER

Sponsor Role: lead

Responsible Party

Yu Dai

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Shenzhen Maternal and Child Health Hospital

Shenzhen, Guangdong, China

Site Status: RECRUITING

Countries

China

Central Contacts

Yu Dai, Associate Professor

Role: CONTACT

daiyu829@163.com

13828718985

Facility Contacts

Ping Jin, Professor

Role: primary

13925206896@163.com

13925206896

Other Identifiers

2021KFKT030

Identifier Type: -

Identifier Source: org_study_id